CW June 2004
Volume 13Issue Number 6 June 2004 ISSN 10593802 Novel Albumin-bound Paclitaxel Superior for Advanced Breast CancerA novel albumin-bound version of the cancer drug paclitaxel shows superior anti-tumor activity and less toxicity compared to standard paclitaxel (Taxol) for the treatment of metastatic breast cancer (MBC).
Go to Previous Page Go to Next Page Source & Additional Reading American Society of Clinical Oncology Annual Meeting Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW June 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
